Advertisement
Screener

Global Blood Therapeutics, Inc. Increase (Decrease) in Other Current Assets

Global Blood Therapeutics, Inc. Increase (Decrease) in Other Current Assets

Global Blood Therapeutics, Inc. reported Increase (Decrease) in Other Current Assets of $23.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2021-02-24

  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2016-12-31 was $509.00K.
  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2016-09-30 was -$9.00K, a 105.88% decline year-over-year.
  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2016-06-30 was $9.00K.
  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for the quarter ending 2016-03-31 was $3.00K, a 99.17% decline year-over-year.
  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2020 was $23.00K, a 98.91% decline from fiscal 2019.
  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2019 was $2.11M, a 65.26% increase from fiscal 2018.
  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2018 was $1.28M, a 688.89% increase from fiscal 2017.
  • Global Blood Therapeutics, Inc. increase (decrease) in other current assets for fiscal 2017 was $162.00K, a 68.36% decline from fiscal 2016.
Period endIncrease (Decrease) in Other Current Assets 3 monthIncrease (Decrease) in Other Current Assets 6 monthIncrease (Decrease) in Other Current Assets 9 monthIncrease (Decrease) in Other Current Assets 12 month
2020-12-31$23.00K
10-K · filed 2021-02-24
2019-12-31$2.11M
10-K · filed 2021-02-24
2018-12-31$1.28M
10-K · filed 2021-02-24
2017-12-31$162.00K
10-K · filed 2020-02-26
2016-12-31$509.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$500.00K
derived: sum of 2 quarters · filed 2019-02-27
$509.00K
derived: sum of 3 quarters · filed 2019-02-27
$512.00K
10-K · filed 2019-02-27
2016-09-30-$9.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$0.00
derived: sum of 2 quarters · filed 2016-11-09
$3.00K
10-Q · filed 2016-11-09
-$229.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$9.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
$12.00K
10-Q · filed 2016-08-10
-$220.00K
derived: sum of 3 quarters · filed 2018-02-27
-$67.00K
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$3.00K
10-Q · filed 2016-05-12
-$229.00K
derived: sum of 2 quarters · filed 2018-02-27
-$76.00K
derived: sum of 3 quarters · filed 2018-02-27
-$381.00K
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$232.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$79.00K
derived: sum of 2 quarters · filed 2018-02-27
-$384.00K
derived: sum of 3 quarters · filed 2018-02-27
-$22.00K
10-K · filed 2018-02-27
2015-09-30$153.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$152.00K
derived: sum of 2 quarters · filed 2016-11-09
$210.00K
10-Q · filed 2016-11-09
$574.00K
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$305.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
$57.00K
10-Q · filed 2016-08-10
$421.00K
derived: sum of 3 quarters · filed 2017-03-13
$422.00K
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$362.00K
10-Q · filed 2016-05-12
$726.00K
derived: sum of 2 quarters · filed 2017-03-13
$727.00K
derived: sum of 3 quarters · filed 2017-03-13
2014-12-31$364.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$365.00K
derived: sum of 2 quarters · filed 2017-03-13
$323.00K
10-K · filed 2017-03-13
2014-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$41.00K
10-Q · filed 2015-11-12
2014-06-30-$42.00K
10-Q · filed 2015-09-24
2013-12-31-$149.00K
10-K · filed 2016-03-29